Applied StemCell, Inc. (“ASC”), a genome engineering company with deep expertise in induced pluripotent stem cell (iPSC) technology and Cellipont Bioservices, a cell therapy contract development and m ...

Continuity Biosciences and Breakthrough T1D, the leading global type 1 diabetes (T1D) advocacy organization, today announced a strategic collaboration to advance Continuity's NICHE® cell-therapy ...

Cohen says he looked at around two dozen companies since Acorda wound down. Oryon Cell Therapies, with its funding, data and ...

Living therapies, made of engineered immune cells – and capable of hunting down cancer, reversing autoimmune disease and ...

As cell therapy advances toward clinical reality, iPSC-derived cellular products, in vivo reprogramming strategies, and manufacturing-ready reagent platforms are reshaping regenerative medicine and ...

When stem cells are injected into thick tissues, they often clump together and die from lack of oxygen or nutrients, making ...

Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with Parkinson’s disease. Phase 1b/2a data showed that the asset can improve ...

Following through with its sizable investment commitment in China, AstraZeneca on Thursday unveiled plans to build a commercial cell therapy manufacturing base and an innovation center dedicated to | ...

Pharmaceutical companies are shifting from the development of autologous cell therapies to allogeneic cell therapies.

Researchers from Xi'an Jiaotong-Liverpool University (XJTLU) in China have developed a streamlined process that makes it ...

Sartorius has collaborated with ElevateBio, a cell therapy CDMO, among other partners, to test the Eveo platform.

For Floridians who once considered traveling to Latin America or overseas for stem cell therapy, there is now a domestic ...